Purpose: To assess changes in the thickness of the subfoveal retina and choroid after phacoemulsification using enhanced depth imaging optical coherence tomography (EDI-OCT). Methods: A prospective study was conducted on 100 patients. The subfoveal choroidal thickness (SFCT) was measured at 7 points and the retinal thickness was measured at 5 points (before surgery, and 1 day, 1 week, 1 month, and 3 months after surgery). Results: The foveal choroidal thickness showed a thickening trend (but p > 0.05). Compared to the change from baseline to day 1, the changes from baseline were significantly different at nasal 3 mm and 6 mm at all other time points (all p < 0.05). Choroidal thickness changes at temporal 6 mm correlated negatively with intraocular pressure (IOP) at 1 week and 1 month; changes at nasal 3 mm correlated negatively with IOP at 1 week and 1 month (all p < 0.05); changes at nasal 3 mm, temporal 3 mm, and temporal 6 mm correlated with average ultrasonic energy. Choroidal thickness changes correlated with ultrasound (US) time at day 1. Conclusions: Uncomplicated phacoemulsification led to changes in choroidal thickness. IOP and choroidal thickness changes were negatively correlated. The foveal retinal thickness was correlated with age. SFCT was correlated with sex, axial length, IOP, and US time.

1.
Flach AJ: The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 1998;96:557-634.
2.
Yonekawa Y, Kim IK: Pseudophakic cystoid macular edema. Curr Opin Ophthalmol 2012;23:26-32.
3.
Henderson BA, Kim JY, Ament CS, Ferrufino-Ponce ZK, Grabowska A, Cremers SL: Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment. J Cataract Refract Surg 2007;33:1550-1558.
4.
Loewenstein A, Zur D: Postsurgical cystoid macular edema. Dev Ophthalmol 2010;47:148-159.
5.
Shelsta HN, Jampol LM: Pharmacologic therapy of pseudophakic cystoid macular edema: 2010 update. Retina 2011;31:4-12.
6.
Cohen SM, Davis A, Cukrowski C: Cystoid macular edema after pars plana vitrectomy for retained lens fragments. J Cataract Refract Surg 2006;32:1521-1526.
7.
Rashid S, Young LH: Progression of diabetic retinopathy and maculopathy after phacoemulsification surgery. Int Ophthalmol Clin 2010;50:155-166.
8.
Belair ML, Kim SJ, Thorne JE, Dunn JP, Kedhar SR, Brown DM, Jabs DA: Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol 2009;148:128-135 e122.
9.
Miyake K, Ibaraki N, Goto Y, Oogiya S, Ishigaki J, Ota I, Miyake S: ESCRS Binkhorst Lecture 2002: Pseudophakic Preservative Maculopathy. J Cataract Refract Surg 2003;29:1800-1810.
10.
van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, Pameyer JH, de Jong PT: Increased prevalence of disciform macular degeneration after cataract extraction with implantation of an intraocular lens. Br J Ophthalmol 1994;78:441-445.
11.
Anderson DH, Mullins RF, Hageman GS, Johnson LV: A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002;134:411-431.
12.
Pollack A, Marcovich A, Bukelman A, Oliver M: Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology 1996;103:1546-1554.
13.
Penfold PL, Provis JM, Billson FA: Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefes Arch Clin Exp Ophthalmol 1987;225:70-76.
14.
Mainster MA, Ham WT Jr, Delori FC: Potential retinal hazards. Instrument and environmental light sources. Ophthalmology 1983;90:927-932.
15.
Libre PE: Intraoperative light toxicity: a possible explanation for the association between cataract surgery and age-related macular degeneration. Am J Ophthalmol 2003;136:961.
16.
Ohsugi H, Ikuno Y, Ohara Z, Imamura H, Nakakura S, Matsuba S, Kato Y, Tabuchi H: Changes in choroidal thickness after cataract surgery. J Cataract Refract Surg 2014;40:184-191.
17.
Manjunath V, Taha M, Fujimoto JG, Duker JS: Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol 2010;150:325-329.e1.
18.
Wei WB, Xu L, Jonas JB, Shao L, Du KF, Wang S, Chen CX, Xu J, Wang YX, Zhou JQ, You QS: Subfoveal choroidal thickness: the Beijing Eye Study. Ophthalmology 2013;120:175-180.
19.
Rahman W, Chen FK, Yeoh J, Patel P, Tufail A, Da Cruz L: Repeatability of manual subfoveal choroidal thickness measurements in healthy subjects using the technique of enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci 2011;52:2267-2271.
20.
Odrobina D, LaudaŃska-Olszewska I: Choroidal thickness in clinically significant pseudophakic cystoid macular edema. Retina 2015;35:136-140.
21.
Noda Y, Ogawa A, Toyama T, Ueta T: Long-term increase in subfoveal choroidal thickness after surgery for senile cataracts. Am J Ophthalmol 2014;158:455-459 e451.
22.
Pierru A, Carles M, Gastaud P, Baillif S: Measurement of subfoveal choroidal thickness after cataract surgery in enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci 2014;55:4967-4974.
23.
Yilmaz T, Karci AA, Yilmaz I, Yilmaz A, Yildirim Y, Sakalar YB: Long-term changes in subfoveal choroidal thickness after cataract surgery. Med Sci Monit 2016;22:1566-1570.
24.
Miyake K, Ibaraki N: Prostaglandins and cystoid macular edema. Surv Ophthalmol 2002;47(suppl 1):S203-S218.
25.
Miyake K, Nishimura K, Harino S, Ota I, Asano S, Kondo N, Miyake S: The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Invest Ophthalmol Vis Sci 2007;48:5647-5652.
26.
Xu H, Chen M, Forrester JV, Lois N: Cataract surgery induces retinal pro-inflammatory gene expression and protein secretion. Invest Ophthalmol Vis Sci 2011;52:249-255.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.